AG
CORT icon

Advisor Group’s Corcept Therapeutics CORT Stock Holding History

Advisor Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Sell
187
-445
-70% -$6.2K ﹤0.01% 4961
2019
Q3 		$8K Buy
632
+40
+7% +$492 ﹤0.01% 4447
2019
Q2 		$6K Sell
592
-2,864
-83% -$31.9K ﹤0.01% 4591
2019
Q1 		$41K Sell
3,456
-5,959
-63% -$74K ﹤0.01% 3516
2018
Q4 		$125K Sell
9,415
-1,910
-17% -$25.2K ﹤0.01% 2452
2018
Q3 		$158K Sell
11,325
-143
-1% -$2K ﹤0.01% 2368
2018
Q2 		$180K Buy
11,468
+3,645
+47% +$63.4K ﹤0.01% 2055
2018
Q1 		$129K Sell
7,823
-5,350
-41% -$99.1K ﹤0.01% 2334
2017
Q4 		$239K Buy
13,173
+10,278
+355% +$186K ﹤0.01% 1849
2017
Q3 		$55K Sell
2,895
-2,043
-41% -$30.5K ﹤0.01% 2871
2017
Q2 		$58K Buy
4,938
+3,810
+338% +$41.4K ﹤0.01% 2721
2017
Q1 		$12K Buy
+1,128
New +$9.91K ﹤0.01% 3673

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Group's CORT Position: Q4 2019 in Review

Advisor Group reduced its Corcept Therapeutics (CORT) stake by 70% in Q4 2019, selling an estimated $6.2K and leaving 187 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4961.

Advisor Group first reported a position in CORT in Q1 2017 and has held it in 12 quarters since. The position peaked at $239K in Q4 2017. 205 funds tracked by Wall St. Rank hold CORT as of Q4 2019.

  • Advisor Group held 187 shares of Corcept Therapeutics worth $2K as of Q4 2019.
  • Advisor Group sold 445 Corcept Therapeutics shares in Q4 2019, an estimated $6.2K.
  • Corcept Therapeutics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4961 holding.
  • Advisor Group first reported a position in Corcept Therapeutics in Q1 2017 and has held it in 12 quarters since.
  • Advisor Group's Corcept Therapeutics position peaked at $239K in Q4 2017.
  • 205 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.